lenalidomide has been researched along with Central Hypothyroidism in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, TD; Hazan, E; Jabbour, SA; Keller, MS | 1 |
| Cao, X; Gao, X; Huang, X; Li, J; Xia, W; Yang, H; Zhao, H; Zhou, D | 1 |
| Appetecchia, M; Baldelli, R; Barnabei, A; Corsello, SM; Paragliola, R; Torino, F | 1 |
| Dahlman, KB; Hames, ML; Iams, WT; Reddy, NM; Richards, KL; Talbott, MS; Tsai, JP | 1 |
| Ikeda, T; Kimura, F; Okamura, I; Sato, K | 1 |
| Kurtin, SE | 1 |
| Hamnvik, OP; Larsen, PR; Marqusee, E | 1 |
| Habermann, T; Menon, S; Witzig, T | 1 |
2 review(s) available for lenalidomide and Central Hypothyroidism
| Article | Year |
|---|---|
Thyroid dysfunction as an unintended side effect of anticancer drugs.
Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bexarotene; Diphtheria Toxin; Humans; Hypothyroidism; Interferon-alpha; Interleukin-2; Lenalidomide; Neoplasms; Recombinant Fusion Proteins; Tetrahydronaphthalenes; Thalidomide; Thyroid Diseases; Thyroid Gland; Thyroid Hormones; Thyroxine | 2013 |
Thyroid dysfunction from antineoplastic agents.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Anticarcinogenic Agents; Antineoplastic Agents; Bexarotene; Diphtheria Toxin; Humans; Hyperthyroidism; Hypopituitarism; Hypothyroidism; Interferon-alpha; Interleukin-2; Iodine Radioisotopes; Ipilimumab; Lenalidomide; Molecular Targeted Therapy; Neoplasms; Protein-Tyrosine Kinases; Quality of Life; Radioimmunotherapy; Recombinant Fusion Proteins; Recombinant Proteins; Tetrahydronaphthalenes; Thalidomide; Thyroid Function Tests; Thyroid Gland; Thyroid Hormones; Thyroiditis, Autoimmune | 2011 |
1 trial(s) available for lenalidomide and Central Hypothyroidism
| Article | Year |
|---|---|
Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hypothyroidism; Immunologic Factors; Interferon-gamma; Interleukin-12; Interleukin-15; Interleukin-6; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Rituximab; Severity of Illness Index; Thalidomide; Tumor Necrosis Factor-alpha | 2015 |
5 other study(ies) available for lenalidomide and Central Hypothyroidism
| Article | Year |
|---|---|
Scleromyxedema in a patient with thyroid disease: an atypical case or a case for revised criteria?
Topics: Adult; Diagnosis, Differential; Female; Hashimoto Disease; Humans; Hypothyroidism; Immunoglobulins, Intravenous; Lenalidomide; Scleromyxedema | 2020 |
Endocrine Evaluation in POEMS Syndrome: A Cohort Study.
Topics: Adrenal Insufficiency; Adult; Aged; Angiogenesis Inhibitors; Dexamethasone; Female; Humans; Hypogonadism; Hypothyroidism; Lenalidomide; Male; Middle Aged; POEMS Syndrome; Young Adult | 2020 |
[Thalidomide-associated hypothyroidism in a patient with multiple myeloma].
Topics: Aged; Constipation; Humans; Hypothyroidism; Lenalidomide; Male; Multiple Myeloma; Thalidomide; Thyroid Function Tests | 2015 |
Hypothyroidism: a growing complication of cancer treatment.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Female; Humans; Hypothyroidism; Incidence; Iodide Peroxidase; Lenalidomide; Male; Neoplasms; Radioimmunotherapy; Radiotherapy; Thalidomide; United States | 2009 |
Lenalidomide-associated hypothyroidism.
Topics: Antineoplastic Agents; Female; Humans; Hypothyroidism; Lenalidomide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Thalidomide | 2007 |